Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis.

The main purpose of the present study was to investigate the labor market affiliation of NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Nationwide retrospective study of all patients with NSCLC in Denmark diagnosed between 2012 and 2018. During the study period NSCLC patients had a median overall survival of 44.

Clinical outcomes of + non-small cell lung cancer in Denmark.

Background: Real-world clinical outcomes of anaplastic lymphoma kinase positive (+) non-small cell lung cancer (NSCLC) patients vary. This study aimed to investigate the treatment and clinical outcomes of all + NSCLC patients in Denmark in the period 2011-2018, regardless of disease stage.

Materials And Methods: A national pathology database with complete coverage was used to identify + NSCLC patients diagnosed between 2011 and 2018.